Mystic, CT, United States of America

Thomas V Magee


Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 148(Granted Patents)


Location History:

  • New York, NY (US) (1995 - 1996)
  • Groton, CT (US) (2005 - 2006)
  • Mystic, CT (US) (1996 - 2008)
  • Winchester, MA (US) (2017 - 2023)

Company Filing History:


Years Active: 1995-2023

Loading Chart...
18 patents (USPTO):

Title: The Innovative Contributions of Thomas V. Magee

Introduction

Thomas V. Magee, an accomplished inventor based in Mystic, CT, has made significant strides in the field of pharmaceuticals, particularly in the development of ketohexokinase inhibitors. With a remarkable portfolio of 18 patents, Magee has showcased his innovative spirit and commitment to advancing medical science.

Latest Patents

Among his recent contributions are his patents for "Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors." These inventions involve the creation of substituted 3-azabicyclo[3.1.0]hexanes, which serve as inhibitors for ketohexokinase. The patents detail processes for synthesizing these compounds, alongside methods for administering them to mammals requiring treatment. This innovation highlights Magee's ongoing dedication to addressing critical health challenges.

Career Highlights

Throughout his career, Thomas V. Magee has demonstrated a strong affiliation with leading research organizations. He has worked with Pfizer Corporation, one of the largest pharmaceutical companies in the world, where he contributed to innovative drug research and development. Additionally, his tenure at the Sloan Kettering Institute for Cancer Research has allowed him to collaborate on ground-breaking cancer research, further reflecting his commitment to enhancing healthcare solutions.

Collaborations

Magee's professional journey has been enriched by collaborations with other notable professionals in his field. He has worked alongside colleagues such as Anthony Marfat and Robert James Chambers, contributing to a diverse array of projects aimed at fostering innovative approaches to health and medicine. These partnerships have not only broadened his perspective but also have advanced collective research efforts.

Conclusion

In conclusion, Thomas V. Magee stands out as a prominent inventor whose contributions have significantly impacted the pharmaceutical landscape. With a solid record of patents and a history of collaboration with esteemed organizations and talented professionals, Magee continues to be a beacon of innovation in the quest for improved medical treatments. His work exemplifies the essence of dedication and creativity that characterizes successful inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…